Page last updated: 2024-10-30

mebendazole and Pelvic Inflammatory Disease

mebendazole has been researched along with Pelvic Inflammatory Disease in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.

Research Excerpts

ExcerptRelevanceReference
"Strongyloidiasis is a potentially life-threatening condition which, when appropriately diagnosed early in its course, is easily eradicated."1.28Pelvic inflammatory disease complicated by massive helminthic hyperinfection. ( Faro, S; Mason, BA; Young, RL; Zund, G, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Young, RL1
Zund, G1
Mason, BA1
Faro, S1

Other Studies

1 other study available for mebendazole and Pelvic Inflammatory Disease

ArticleYear
Pelvic inflammatory disease complicated by massive helminthic hyperinfection.
    Obstetrics and gynecology, 1989, Volume: 74, Issue:3 Pt 2

    Topics: Adult; Female; Humans; Mebendazole; Parasite Egg Count; Pelvic Inflammatory Disease; Strongyloidiasi

1989